Hospitals Cry Foul After Eli Lilly Withholds 340B Discounts

Katie Adams / medcitynews - Eli Lilly made good on its threat to withhold 340B drug discounts from hospitals that refused to submit claims data. Hospital groups are calling the policy unlawful, arguing that the company has no legal authority to create its own compliance requirements…

AI Summary: Eli Lilly has begun denying 340B program discounts to participating hospitals after issuing an ultimatum, prompting sharp criticism from safety-net providers. Hospitals say the move will squeeze margins and threaten patient access to affordable medicines. The dispute centers on manufacturer discount eligibility and contract terms as providers scramble to quantify the financial hit.